A recent study published in JAMA Network Open found that a low-fat vegan diet can lead to weight loss comparable to the injectable medication semaglutide over a 16-week period. Participants on the vegan diet experienced significant reductions in calorie intake and increases in f…
GLP-1 medications, including Ozempic and Wegovy, are linked to unexpected side effects such as hair loss. This occurs primarily due to a condition called telogen effluvium, trigge…
Recent research highlights that weight loss is not merely a matter of willpower but is influenced by biological mechanisms in the brain that defend against weight loss. This under…
Researchers at Stanford Medicine have discovered a naturally occurring peptide, BRP, that may suppress appetite through a targeted pathway, potentially offering a new approach to…
The Medicines and Healthcare products Regulatory Agency (MHRA) emphasizes the importance of safe practices in weight loss, particularly regarding GLP-1 medications. As demand for…
A recent study has found that GLP-1 drugs like Wegovy and Ozempic, used for obesity and type 2 diabetes, may be associated with a higher risk of hair loss, particularly non-scarri…
A recent study from the University of Copenhagen highlights the significant role of exercise in enhancing cardiovascular health among individuals with severe obesity, even after s…
As GLP-1 medications like Wegovy and Mounjaro gain popularity for weight loss, concerns arise about the potential for yo-yo dieting once treatment stops. Evidence suggests that ma…
A recent analysis reveals that while obesity drugs like GLP-1s can lead to significant weight loss, they often do not enhance quality of life or cardiovascular health for many pat…
A recent analysis published in the British Medical Journal scrutinizes the effectiveness of popular obesity medications like Wegovy and Mounjaro, revealing that while these drugs…
Recent discussions highlight the potential for yo-yo dieting associated with GLP-1 weight-loss medications like Wegovy and Mounjaro. While these drugs can be effective in aiding w…
A recent study reveals that UK households using weight-loss medications like Wegovy and Mounjaro are spending significantly less on groceries, with an average reduction of £418 in…
As 'Ozempic face' becomes a trending concern after weight loss from GLP-1 medications, surgeons adapt by offering innovative treatments to restore youthful facial volume and featu…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
Eli Lilly is targeting a revenue milestone of $100 billion by fiscal 2026, supported by strong growth in its incretin franchise and a bullish price target of $1,480. The company's…